Evidence map›Paper›PMID 35342139›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Drastic Improvement in Hepatitis B/C Virus-induced Decompensated Liver Cirrhosis Treated by Total Management Consisting of Interventional Radiology, Endoscopy, and Pharmacotherapy.

Tatsuro Nishimura, Tsuyoshi Ishikawa, Daiki Kawamoto, Ryo Sasaki, Takashi Matsuda, Taro Takami

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tatsuro NishimuraDepartment of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Japan.
Tsuyoshi IshikawaDepartment of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Japan.
Daiki KawamotoDepartment of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Japan.
Ryo SasakiDepartment of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Japan.
Takashi MatsudaDepartment of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Japan.
Taro TakamiDepartment of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Japan.
Yamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in antiviral therapy have enabled control of the hepatitis virus; however, these do not completely eliminate the pathological condition of liver disease, and portal hypertension remains a clinical problem. We herein report a case of hepatitis B virus/hepatitis C virus (HBV/HCV)-induced decompensated liver cirrhosis for which total management consisting of interventional radiology and endoscopy, based on the evidence of our clinical studies, followed by antiviral therapy for co-infection with HBV and HCV was successful. This case clearly indicates the effective timing of total management, suggesting that it prolongs the vital prognosis in addition to improving the hepatic function.

Indexed as

Hepatitis BHepatitis CAntiviral AgentsEndoscopy, GastrointestinalHepacivirusHumansLiver CirrhosisRadiology, InterventionalAntiviral Agentsballoon-occluded retrograde transvenous obliterationdecompensated liver cirrhosisdirect-acting antiviralendoscopic injection sclerotherapy with ligationnucleic acid analogpartial splenic embolization

Identifiers

PMID35342139
PMCPMC9683805
OpenAlexW4220667488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.